Diseases
Companies
Products
Productz
Mechanisms of Action
Sites
IMGN388
/
AbbVie
Welcome,
Profile
Billing
Logout
0 Diseases
0 Trials
0 Trials
2 News
|||
|||||||
IMGN388
/
ImmunoGen
Trial completion:
A Phase I Dose-Escalation Study of IMGN388 in Patients With Solid Tumors
(clinicaltrials.gov) - Sep 11, 2013
P1
, N=60, Completed,
Sponsor: ImmunoGen, Inc.
Active, not recruiting --> Completed
||
||||||||
IMGN388
/
ImmunoGen
Enrollment change:
A Phase I Dose-Escalation Study of IMGN388 in Patients With Solid Tumors
(clinicaltrials.gov) - May 21, 2012
P1
, N=60, Completed,
Sponsor: ImmunoGen, Inc.
Active, not recruiting --> Completed N=90 --> 60